申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:EP0118565A1
公开(公告)日:1984-09-19
1,4-Methano-2,3,4,5-tetrahydro-1H-2-benzazepine-3-one derivatives represented by the general formula (I), wherein X represents halogen, n represents 1 or 2, and R represents hydrogen, lower alkyl or phenyl-substituted lower alkyl. They are useful as brain function-improving agents antispasmodics, antiepileptics, tranquilizers, etc.
1,4-甲桥-2,3,4,5-四氢-1H-2-苯并氮杂卓-3-酮衍生物,由通式(I)代表,其中 X 代表卤素,n 代表 1 或 2,R 代表氢、低级烷基或苯基取代的低级烷基。它们可用作脑功能改善剂、解痉剂、抗癫痫剂、镇静剂等。